MURIEL BOWSER
MAYOR
October 26, 2023
The Honorable Phil Mendelson
Chairman
Council of the District of Columbia
John A. Wilson Building
1350 Pennsylvania Avenue, NW, Suite 504
Washington, DC 20004
Dear Chairman Mendelson:
In accordance with section 2 of the Confirmation Act of 1978, effective March 3, 1979 (D.C.
Law 2-142; D.C. Official Code § 1- 523.01) , and pursuant to section 3042 of the Fatality Review
Committee Amendment Act of 2018, effective October 30, 2018 (D.C. Law 22- 168; D.C.
Official Code § 5-1431.01), I am pleased to nominate the following individual :
Dr. Eric Li
Fernwood Road
Bethesda, MD 20817
for reappointment as a representative of a District hospital member of the Violence Fatality
Review Committee , for a term to end October 12, 2025.
Enclosed you will find biographical information detailing the experience of the above-mentioned
nominee, together with proposed resolutions to assist the Council during the confirmation process.
I would appreciate the Council’s earliest consideration of this nomination for confirmation. Please do not hesitate to contact me, or Steven Walker, Director, Mayor’s Office of Talent and Appointments, should the Council require additional information. Sincerely,
Muriel Bowser 1
2
3
4
5
6
7
8
9
10
11
12
at the request of the Mayor
A PROPOSED RESOLUTION
IN THE COUNCIL OF THE DISTRICT OF COLUMBIA
13 To confirm the reappointment of Dr. Eric Li to the Violence Fatality Review Committee.
14
15 RESOLVED, BY THE COUNCIL OF THE DISTRICT OF COLUMBIA, That this
16 resolution may be cited as the "Violence Fatality Review Committee Dr. Eric Li Confirmation
17 Resolution of 2023".
18
19 Sec. 2. The Council of the District of Columbia confirms the reappointment of:
20
21
22
23
24
Dr. Eric Li
Femwood Road
Bethesda, MD 20817
25 as a representative of a District hospital member of the Violence Fatality Review Committee,
26 established by section 3042 of the Fatality Review Committee Amendment Act of 2018,
27 effective October 30, 2018 (D.C. Law 22-168; D.C. Official Code§ 5-1431.01), for a term to
28 end October 12, 2025.
29 Sec. 3. The Council of the District of Columbia shall transmit a copy of this resolution,
30 upon its adoption, to the nominee and to the Office of the Mayor.
31 Sec. 4. This resolution shall take effect immediately. Eric Li, M.D.
Interim Chief Medical Officer
and
Chairman, Department of Pathology
United Medical Center
1310 Southern Ave, SE
Washington, DC 20032 E-mail: eli@united-medicalcenter.com
Professional Summary:
I am a leader, physician, and educator. I have worked and trained at some of United
States most prestigious universities.
Professional Interest:
Provide the highest level of quality service to medical center and University hospital.
Participate pathology service.
Professional Experience:
United Medical Center 2017 – 9/2019
Interim Chief Medical Officer
• Responsible for all hospital operations.
In 2017, I became Chief Medical Officer in United medical Center on interim basis . This
is most senior position. United medical Center belongs to Washington DC and one of
oldest public hospital in the country. I was responsible for managing the operation of the entire hospital. I served as a member of the hospital’s board of directors. Since assume
this position, we overcome paramount challenges. We are currently building a new
hospital together with George Washington University .
United Medical Center 2016 – Present
Chairman, Department of Pathology
• Responsible for Anatomical and Clinical Pathology services.
VA Hudson Valley Health Care System 2015 – 2016
Pathologist, Department of Pathology
• Anatomical and Clinical pathology services.
Columbia Memorial Hospital, Hudson, NY 2009 - 2015
Clifton Fine Hospital, New York
Director, Department of Pathology
• Responsible for Anatomical and Clinical Pathology services. Eric Y. Li, M.D.
Page 2
(Continued)
In 2009, I became the Director of the Pathology department at Columbia Memorial
Hospital. I was also responsible for managing the operation of the entire department as
well as overseeing departmental compliance and regulations. I served as a member of the
hospital’s medical executive committee.
Claxton-Hepburn Medical Center, Ogdensburg, NY 2003 - 2009
Clifton Fine Hospital, New York
Director, Department of Pathology
• Responsible for Anatomical and Clinical P athology services.
In 2003, I became the Director of the Pathology department at Claxton- Hepburn Medical
Center. Clinical pathology and manage ment of the laboratory were important parts of my
responsibility. I was responsible for managing the operation of the entire department as
well as overseeing departmental compliance and regulations. I served as a member of the
hospital’s medical executive committee.
New York University Medical Center, New York, NY 2002- 2003
Assistant Professor, Department of Pathology
• Studied cytology and OB/GYN pathology.
St. Johns Riverside Hospital at Yonkers, NY 2001- 2002
Director, Department of Pathology
• Responsible for Anatomical and Clinical Pathology services.
New York University Medical Center, New York, NY 2000- 2001
Assistant Professor, Department of Pathology
• Responsible for Anatomical Pathology services, teaching fellows, residents, medical
students and research.
During this period, I served as the attending physician at the New York University Medical Center. It was an academic setting that utilized a multiple discipline approach.
The hospital is famous for the complex cases it receives and the expertise among its
Pathologists. I was a key member of the surgical pathology team and was responsible
for the selection and recruiting of pathology fellowship candidates. I was engaged in
cancer research and maintained an American Cancer Society grant. I also teach medical
students. I have given lectures on Tuberculosis infection and was the Lab leader on
inflammatory pathology. Dartmouth-Hitchcock Medical Center/Weeks Hospital 1998-1999
Attending Pathologist, Department of Pathology
• Responsible for Anatomical and Clinical Pathology services.
• Chief Inspector, College of American Pathologists.
Dartmouth-Hitchcock Medical Center/VA Hospital, WRJ, VT 1997
• Responsible for Anatomical Pathology and overseeing departmental operation. Eric Y. Li, M.D.
Page 3
(Continued)
• Educate residents and worked as Lab leader on cardiovascular pathology.
Clinical and Postgraduate Training:
Johns Hopkins Hospital, Maryland, MD 1999-2000
Fellowship in Hepatic and Gastrointestinal Pathology
Dartmouth-Hitchcock Medical Center 1997-1998
Clinical Pathology Resident, Department of Pathology,
Dartmouth-Hitchcock Medical Center 1995-1996
Clinical Pathology Resident, Department of Pathology,
Yale-New Haven Hospital, CT 1993-1995
Anatomic Pathology Resident, Department of Pathology, Yale University, School of Medicine, CT 1992-1993
Post-doctoral associate, Department of Pathology
Yale University, School of Medicine, CT 1988-1992
Post-doctoral associate, Department of pharmacology
Peking Union Medical College 1986-1988 Lecturer, Department of pharmacology
Licensure and Certification
2016 Registered Physician, Board of Registration in Medicine, Washington D.C. 2000 Registered Physician, Board of Registration in Medicine, State of New York 1999 Registered Physician, Board of Registration in Medicine, State of Vermont 1998 Diplomat, American Board of Pathology (Anatomic Pathology) 1998 Diplomat, American Board of Pathology (Clinical Pathology) 1997 Registered Physician, Board of Registration in Medicine, State of New Hampshire
Education:
1983-1986 M.D., Peking Union Medical College, Chinese Academy of Medical
Sciences, Beijing, China
1978-1982 Bachelor of Medicine, Nanjing Railway Medical College, China
SELECT PUBLICATIONS
Eric Y. Li, M.D.
Page 4
(Continued)
Refereed Journal Publications, investigative science
1. Dianne Pulte, M.D.
, Eric Li, M.D.
, Bernard K. Crawford, M.D.
, Elliot Newman,
M.D.
, Alice Alexander, Ph.D.
, David C. Mustalish
, Daniel R. Jacobson, M.D.
Sentinel Lymph Node Mapping and Molecular Staging in Non-Small Cell Lung
Cancer. Cancer. 2005, vol. 104, n
o
7, pp. 1453-1461
2. Jianjun Wei, Luis Chiriboga, Herman Yee, Masashi Mizuguchi, Eric Li , Gurdip
S. Sidhu, and A. Brian West. Altered Cellular Distribution of Tuberin and Glucocorticoid Receptor in Sporadic Fundic Gland Polyps. Mod. Pathol. 2002 15: 862-869
3. Carole Hazan, Kate Melzer, Katherine S. Panageas, Eric Li, Hideko Kamino, Alfred Kopf, Carlos Cordon-Cardo, Iman Osman, David Polsky. Evaluation of the proliferation marker MIB-1 in the prognosis of cutaneous malignant melanoma.
Cancer 95, 3: 634-640
4. H. Xiao, E. Li, Y. Makeyev, N. Dean, B. Vikram, W. A. Franklin Inhibition of Bcl-xL, an Anti-Apoptotic Protein, by Antisense Oligonucleotide
Potentiated g-radiation Induced Apoptosis in Human Adenocarcinoma of the Lung. Radiation Research, submitted.
5. E. Li, H. Xiao, B. Vikram, Differential Expression of Bcl-2 and Bcl-xL in
Human Small Cell Lung Cancer and Adenocarcinoma of the Lung. Submitted.
6. David B. Bregman, Lei Du, Eric Li, Stephen Ribose and Stephen L. Warren. Cytostellin distributes to nuclear regions enriched with splicing factors. Journal of
Cell Science 107, 387-396, 1994.
7. Eric Li, Lyndon Lewellen and Edward Moczydlowski. Biochemical and
Immunochemical comparison of Saxiphilin and transferrin, two structurally
related plasma proteins from Rana Catesbeiana. Molecular Pharmacology 44(4):
742-748, 1993.
8. Eric Li, and Edward Moczydlowski. Purification and partial sequencing of
Saxiphilin, a saxitoxin-binding protein from the bullfrog, reveal homology to
transferrin. Journal of Biological Chemistry, 266: 15481-15487, 1991.
9. Janice Mahar, Gergely L. Lukacs, Eric Li, Sherwood Hall and Edward
Moczydlowski. Pharmacological and biochemical properties of Saxiphilin, a
soluble saxitoxin-binding protein from the bullfrog (Rana Catesbeiana). Toxicon,
29: 53-71, 1991.
Symposium Proceedings
10. Eric Li, Helen Xiao and Bhadrasain Vikram. Differential expression of Bcl-2 and Bcl-xL in human small cell lung cancer (sclc) and adenocarcinoma of the lung
(ACL). United States and Canadian Academy of Pathology. Annual Meeting, Atlanta, Georgia, USA, 2001.
11. Eric Li, Helen Xiao and Bhadrasain Vikram. Bcl-xL, overexpressed in human
lung adenocarcinoma (acl), is an ideal target for antisense therapy. United States and Canadian Academy of Pathology. Annual Meeting, Atlanta, Georgia, USA, 2001. Accepted as platform presentation. Eric Y. Li, M.D.
Page 5
(Continued)
12. Eric Li and Anna Mae Diehl. Un-coupling Protein 2 expression in acute alcoholic
hepatitis. United States and Canadian Academy of Pathology. Annual Meeting, New Orleans, LA, USA, 2000
13. Frank Polito, Eric Li, Kiang- Teck Yeo. Clinical evaluation of the cornine 855
blood gas electrolyte co- oximeter system. AACC Meetings, Washington, DC.
USA, 1996
14. Eric Li, and Edward Moczydlowski. Purification and partial sequencing of Saxiphilin, a saxitoxin- binding protein from the bullfrog, reveal homology to
transferrin. 1990 Yale Department of Pharmacology annual research conference.
Executive Office of the Mayor - Office of Talent and Appointments
John A. Wilson Building | 1350 Pennsylvania Avenue, Suite 600 | Washington, DC 20004
Dr. Eric Li
Dr. Eric Li was brought on at United Medical Center as the Chairman
of the Department of pathology in 2016. In 2017, Dr. Eric Li became
Interim Chief Medical Officer at United M edical Center, one of the
oldest public hospital s in the country. While there, he was responsible
for managing the operations of the entire hospital, and has even served
as a member of the hospital’s B oard of Directors. Since assuming the
role as Interim Chief Medical Officer, he has helped the hospital
overcome paramount challenges. In September 2019 his time as
Interim Chief Medical Officer ended, and he continues to serve as the
Chairman of the hospital’s Pathology department.
Dr. Li has been studying medicine since 1978, appeared in several publications and conducted
several symposium proceedings. GOVERNMENT OF THE DISTRICT OF COLUMBIA
Executive Office of Mayor Muriel Bowser
Office of the General Counsel to the Mayor
______________________________________________________________________________
The John A. Wilson Building • 1350 Pennsylvania Avenue, NW • Suite 300 • Washington, D.C. 20004 • Office (202) 724 -7681
To: Tommy Wells, Steve Walker
From: Betsy Cavendish
Date: July 28, 2023
Subject: Legal sufficiency review of Resolutions nominating Charlayne Hayling- Williams,
Dr. Eric Li, Dr. Erin Hall, Helaina Roisman, Joseph Richardson, Juanita Price, Kenyatta Hazlewood, and Dr. Mallory Williams as members of the Violence
Fatality Review Committee
This is to Certify that this office has reviewed the above- referenced resolutions and
found them to be legally unobjectionable. If you have any questions in this regard, please do not
hesitate to call Vanessa Careiro, Deputy General Counsel, Executive Office of the Mayor, at 202-724-1303, or me at 202- 724-7681.
______________________________ Elizabeth A. (Betsy) Cavendish